在美国心脏协会心脏冲击注册表中的心血管活性使用在心脏冲击中的当代实践模式
Siddharth M Patel1, David D Berg1, Erin A Bohula1
1Levine Cardiac Intensive Care Unit, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital Harvard Medical School Boston MA USA.
Journal of the American Heart Association
|October 28, 2025
概括
在心脏性休克 (CS) 管理中,最常用的是像诺尔上腺素这样的抑制剂. 血管活性剂的实践模式根据CS原因和严重程度而异,为未来的治疗策略提供信息.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 关键护理医学 关键护理医学
背景情况:
- 血管活性剂是心脏性休克 (CS) 的主要治疗方法.
- 目前在CS中选择血管活性剂的做法尚不清楚.
研究的目的:
- 在心脏性休克患者中选择血管活性剂的当代实践模式的特征.
- 在CS管理中确定影响血管活性剂选择的因素.
主要方法:
- 来自美国心脏协会 (AHA) CS注册表 (2022-2024) 的数据分析.
- 包括在发病6小时内接受了血管活性剂治疗的CS入院.
- 药物被分为不压缩剂,扩散剂和纯血管压缩剂.
主要成果:
- 在6847个CS招生中,49.5%获得了一名代理人,50.5%获得两名或更多的代理人.
- 内压剂最常见 (73.7%),其次是内扩展剂 (48.3%) 和纯血管压缩剂 (27.5%).
- 上腺素是最常见的药物 (64.7%),使用模式因CS病因和严重程度而异.
结论:
- 压缩剂,特别是诺阿基因,是当代CS护理中最常用的血管活性剂.
- CS的病因和严重程度显著影响了血管活性剂的选择.
- 这些发现为当前的CS治疗提供了洞察力,并指导未来关于最佳血管活性策略的研究.
相关概念视频
Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


